Stephen P. Ewald net worth and biography

Stephen Ewald Biography and Net Worth

General Counsel of Medpace

Stephen P. Ewald J.D. serves as General Counsel, Corporate Secretary of the Company since June 2012. Mr. Ewald has also led the Human Resources department and other administrative functions since the third quarter of 2017. Prior to joining Medpace, Mr. Ewald served as the Managing Director and Chief Legal Officer of Brevet Capital Management from May 2011 to June 2012. From May 2009 to May 2011, he was a Managing Director and Assistant General Counsel for Cantor Fitzgerald Securities/Cantor Fitzgerald & Co. Mr. Ewald was employed with Bank of America from 1999 to 2009, serving in various roles within the legal department and the Global Markets Group, including Managing Director and Chief Operating Officer of the Principal Capital Group, a proprietary investing group within Bank of America Securities. Mr. Ewald has served as director for several private companies, including as a director and chairman of the board of Mercy Health Foundation Board Cincinnati since 2015 and 2018, respectively, as a director of LIB Therapeutics, LLC since 2015 and as a director of CinRx Pharma, LLC since 2015. Mr. Ewald received his Bachelor of Science in Political Sciences from the University of Cincinnati and his Juris Doctorate from the University of Cincinnati College of Law.

What is Stephen P. Ewald's net worth?: The estimated net worth of Stephen P. Ewald is at least $4.27 million as of February 27th, 2025. Mr. Ewald owns 13,343 shares of Medpace stock worth more than $4,267,025 as of March 26th. This net worth approximation does not reflect any other assets that Mr. Ewald may own. Additionally, Mr. Ewald receives an annual salary of $914,640.00 as General Counsel at Medpace. Learn More about Stephen P. Ewald's net worth.
How old is Stephen P. Ewald?: Mr. Ewald is currently 55 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Stephen P. Ewald's age.
What is Stephen P. Ewald's salary?: As the General Counsel of Medpace Holdings, Inc., Mr. Ewald earns $914,640.00 per year. There are 3 executives that earn more than Mr. Ewald. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,650,000.00 per year. Learn More on Stephen P. Ewald's salary.
How do I contact Stephen P. Ewald?: The corporate mailing address for Mr. Ewald and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at investor@medpace.com. Learn More on Stephen P. Ewald's contact information.
Has Stephen P. Ewald been buying or selling shares of Medpace?: Within the last three months, Stephen P. Ewald has bought $652.22 of Medpace stock. Most recently, on Thursday, February 27th, Stephen P. Ewald bought 2 shares of Medpace stock. The stock was acquired at an average cost of $326.11 per share, with a total value of $652.22. Following the completion of the transaction, the general counsel now directly owns 13,343 shares of the company's stock, valued at $4,351,285.73. Learn More on Stephen P. Ewald's trading history.
Who are Medpace's active insiders?: Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.
Are insiders buying or selling shares of Medpace?: In the last twelve months, Medpace insiders bought shares 1 times. They purchased a total of 2 shares worth more than $652.22. In the last twelve months, insiders at the sold shares 5 times. They sold a total of 29,621 shares worth more than $11,816,851.63. The most recent insider tranaction occured on February, 27th when General Counsel Stephen P Ewald bought 2 shares worth more than $652.22. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.
Information on this page was last updated on 2/27/2025.

Stephen P. Ewald Insider Trading History at Medpace

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/27/2025	Buy	2	$326.11	$652.22	13,343
7/27/2023	Sell	21,850	$254.39	$5,558,421.50	14,854
10/27/2022	Sell	6,500	$220.53	$1,433,445.00	14,854
10/26/2021	Sell	10,000	$209.13	$2,091,300.00
4/14/2021	Sell	1,200	$180.67	$216,804.00	15,054
2/9/2021	Sell	10,000	$155.48	$1,554,800.00	23,854
12/10/2020	Sell	10,000	$140.07	$1,400,700.00	23,854
8/10/2020	Sell	7,400	$121.57	$899,618.00	10,736
10/18/2019	Sell	8,000	$77.30	$618,400.00
3/29/2019	Sell	7,946	$57.95	$460,470.70

Stephen P. Ewald Buying and Selling Activity at Medpace

Medpace Company Overview

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Today's Range

Now: $319.80

$319.45

$325.77

50 Day Range

MA: $337.16

$317.93

$360.97

2 Week Range

Now: $319.80

$302.01

$459.77

Volume

114,840 shs

Average Volume

288,809 shs

Market Capitalization

$9.74 billion

P/E Ratio

25.25

Dividend Yield

N/A

Beta

1.47

Stephen Ewald Biography and Net Worth

What is Stephen P. Ewald's net worth?

How old is Stephen P. Ewald?

What is Stephen P. Ewald's salary?

How do I contact Stephen P. Ewald?

Has Stephen P. Ewald been buying or selling shares of Medpace?

Who are Medpace's active insiders?

Are insiders buying or selling shares of Medpace?